IMDX - Insight Molecular Diagnostics Inc.

Insider Purchase by Broadwood Partners, L.P. (10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Broadwood Partners, L.P., serving as 10% owner at Insight Molecular Diagnostics Inc. (IMDX), purchased 521,739 shares at $5.75 per share, for a total transaction value of $2,999,999.00. Following this transaction, Broadwood Partners, L.P. now holds 23,863,835 shares of IMDX.

This purchase represents a 2.00% increase in Broadwood Partners, L.P.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, February 10, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 12, 2026, 2 days after the trade was made.

Insight Molecular Diagnostics Inc. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Broadwood Partners, L.P.

Broadwood Partners, L.P.

10%

Broadwood Partners, L.P. is a Delaware limited partnership and pooled investment vehicle managed by Broadwood Capital, Inc., a New York City–based private investment firm formed in 2002 and registered with the U.S. Securities and Exchange Commission.[[1]](https://www.snowballresearch.com/activism/activistprofile/broadwood-partners-l-p/)[[5]](https://www.sec.gov/Archives/edgar/data/1278386/000091957423006645/xslFormDX01/primary_doc.xml)[[8]](https://www.broadwoodcapital.com) Broadwood Partners, L.P. is one of Broadwood Capital’s primary advisory clients and serves sophisticated investors through an actively managed portfolio reviewed on a daily basis, with reporting provided under the terms of its limited partnership agreement.[[1]](https://www.snowballresearch.com/activism/activistprofile/broadwood-partners-l-p/) The partnership is organized in Delaware and maintains its principal business contact through Broadwood Capital, Inc. at offices in New York.[[5]](https://www.sec.gov/Archives/edgar/data/1278386/000091957423006645/xslFormDX01/primary_doc.xml) Broadwood Partners, L.P. is best known as a significant, long-term shareholder and activist investor in healthcare and medical technology companies, including its role as a more-than 10% owner of STAAR Surgical Company (NASDAQ: STAA).[[2]](https://www.gurufocus.com/insider/23149/broadwood-partners-lp)[[7]](https://www.businesswire.com/news/home/20260106480307/en/Broadwood-Partners-Comments-on-STAAR-Surgical-Shareholders-Rejection-of-the-Companys-Proposed-Sale-to-Alcon) As of recent SEC ownership reports, Broadwood Partners, L.P. and affiliates have held a substantial stake in STAAR Surgical and have publicly engaged with the company’s strategic direction, including commenting on shareholder actions related to a proposed sale of STAAR to Alcon Inc.[[2]](https://www.gurufocus.com/insider/23149/broadwood-partners-lp)[[7]](https://www.businesswire.com/news/home/20260106480307/en/Broadwood-Partners-Comments-on-STAAR-Surgical-Shareholders-Rejection-of-the-Companys-Proposed-Sale-to-Alcon) Beyond STAAR, the partnership has also reported large, often activist positions in issuers such as Lineage Cell Therapeutics and Insight Molecular Diagnostics, reflecting a concentrated, research-driven investment approach under the leadership of Broadwood Capital’s president and principal owner, Neal C. Bradsher.[[1]](https://www.snowballresearch.com/activism/activistprofile/broadwood-partners-l-p/)[[2]](https://www.gurufocus.com/insider/23149/broadwood-partners-lp)[[3]](https://fintel.io/i/broadwood-partners-lp)

View full insider profile →

Trade Price

$5.75

Quantity

521,739

Total Value

$2,999,999.00

Shares Owned

23,863,835

Trade Date

Tuesday, February 10, 2026

12 days ago

SEC Filing Date

Thursday, February 12, 2026

Filed 2 days after trade

HEALTHCAREDIAGNOSTICS & RESEARCH

About Insight Molecular Diagnostics Inc.

Company Overview

No company information available
View news mentioning IMDX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3930652

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime